Loading...

SpineGuard SA

ALSGD.PA•EURONEXT
Healthcare
Medical - Devices
€0.09
€-0.00(-3.64%)

SpineGuard SA (ALSGD.PA) Stock Overview

Explore SpineGuard SA’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

B

Score: 60.7/100

Key Financials

Market Cap5.7M
P/E Ratio-1.39
EPS (TTM)$-0.06
ROE-0.59%
Fundamental Analysis

AI Price Forecasts

1 Week$0.14
1 Month$0.05
3 Months$0.09
1 Year Target$0.15

ALSGD.PA Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of SpineGuard SA (ALSGD.PA) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 44.47, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $0.15.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -1.39 and a market capitalization of 5.7M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

Technical Indicators

44.47RSI (14)
0.00MACD
17.24ADX
Stats data is not available for ALSGD.PAStats details for ALSGD.PA are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.
Analyst Recommendations data is not available for ALSGD.PAAnalyst Recommendations details for ALSGD.PA are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Company Profile

SpineGuard SA provides designs, develops, and markets medical devices used in surgical procedures worldwide. The company provides PediGuard Straight probe for screw placement; PediGuard Curved probe that includes a tapered tip to enhance the ease of penetrating through pedicle; PediGuard Cannulated probe primarily for helping surgeons reduce radiation exposure during minimally-invasive procedures; and PediGuard Threaded Device, a drilling instrument. It also offers DSG (Dynamic Surgical Guidance) Connect app, which allows collection and visualization of the signal measured at the tip of DSG connect devices during pedicle drilling; and DSG smart screw allows for one step screw placement treatment. The company serves patients, surgeons, operating room staff, and health care providers. SpineGuard SA was founded in 2009 and is headquartered in Vincennes, France.

CEO

Pierre Jérôme

Employees

24

Headquarters

10 Cours Louis LumiEre, Vincennes

Founded

2013

Frequently Asked Questions

;